ES2347166T3 - Amidas de acido carboxilico de tienopirrol sustituidas, amidas de acido carboxilico de pirrolotiazol y analogos relacionados, como inhibidores de la caseina quinasa i epsilon. - Google Patents

Amidas de acido carboxilico de tienopirrol sustituidas, amidas de acido carboxilico de pirrolotiazol y analogos relacionados, como inhibidores de la caseina quinasa i epsilon. Download PDF

Info

Publication number
ES2347166T3
ES2347166T3 ES05826812T ES05826812T ES2347166T3 ES 2347166 T3 ES2347166 T3 ES 2347166T3 ES 05826812 T ES05826812 T ES 05826812T ES 05826812 T ES05826812 T ES 05826812T ES 2347166 T3 ES2347166 T3 ES 2347166T3
Authority
ES
Spain
Prior art keywords
alkyl
carboxylic acid
acid amide
thieno
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05826812T
Other languages
English (en)
Spanish (es)
Inventor
David Marc Fink
Yulin Chiang
Nicola Dawn Collar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2347166T3 publication Critical patent/ES2347166T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
ES05826812T 2004-08-19 2005-08-18 Amidas de acido carboxilico de tienopirrol sustituidas, amidas de acido carboxilico de pirrolotiazol y analogos relacionados, como inhibidores de la caseina quinasa i epsilon. Expired - Lifetime ES2347166T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60334704P 2004-08-19 2004-08-19
US603347P 2004-08-19

Publications (1)

Publication Number Publication Date
ES2347166T3 true ES2347166T3 (es) 2010-10-26

Family

ID=35695546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05826812T Expired - Lifetime ES2347166T3 (es) 2004-08-19 2005-08-18 Amidas de acido carboxilico de tienopirrol sustituidas, amidas de acido carboxilico de pirrolotiazol y analogos relacionados, como inhibidores de la caseina quinasa i epsilon.

Country Status (30)

Country Link
US (2) US7393867B2 (enExample)
EP (1) EP1784409B1 (enExample)
JP (1) JP4869232B2 (enExample)
KR (1) KR20070045263A (enExample)
CN (1) CN100562521C (enExample)
AR (1) AR051008A1 (enExample)
AT (1) ATE471326T1 (enExample)
AU (1) AU2005272584B2 (enExample)
BR (1) BRPI0514419A (enExample)
CA (1) CA2577879C (enExample)
CY (1) CY1110775T1 (enExample)
DE (1) DE602005021889D1 (enExample)
DK (1) DK1784409T3 (enExample)
ES (1) ES2347166T3 (enExample)
GT (1) GT200500215A (enExample)
HR (1) HRP20100475T1 (enExample)
IL (1) IL181158A0 (enExample)
JO (1) JO2629B1 (enExample)
MY (1) MY139831A (enExample)
PA (1) PA8642801A1 (enExample)
PE (1) PE20060630A1 (enExample)
PL (1) PL1784409T3 (enExample)
PT (1) PT1784409E (enExample)
RS (1) RS51413B (enExample)
RU (1) RU2403257C2 (enExample)
SI (1) SI1784409T1 (enExample)
SV (1) SV2006002190A (enExample)
TW (1) TWI372149B (enExample)
UY (1) UY29077A1 (enExample)
WO (1) WO2006021000A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
EP1955699A1 (en) * 2007-02-08 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flibanserin for the treatment of insomnia
JP5420534B2 (ja) 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
EP2397481B1 (en) * 2009-02-12 2014-03-12 Pharmadesign, Inc. Inhibitor of casein kinase 1delta and casein kinase 1epsilon
EP2435443B1 (en) * 2009-05-28 2013-07-31 Vertex Pharmaceuticals Incorporated Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
HRP20140252T1 (hr) * 2009-10-28 2014-04-25 Pfizer Inc. Derivati imidazola kao inhibitori kazeinske kinaze
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
RU2562833C2 (ru) 2010-08-09 2015-09-10 НБ Хелс Лаборатори Ко. Лтд. Ингибитор казеинкиназы 1 дельта и казеинкиназы 1 е
CN109748927A (zh) * 2017-11-03 2019-05-14 上海交通大学医学院附属瑞金医院 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
WO2000075669A1 (en) * 1999-06-08 2000-12-14 Aventis Pharmaceuticals Inc. Screening methods for altering circadian rhythm proteins
AU2004303826A1 (en) * 2003-12-11 2005-07-07 Aventis Pharmaceuticals Inc. Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase I Epsilon

Also Published As

Publication number Publication date
CY1110775T1 (el) 2015-06-10
TW200621788A (en) 2006-07-01
GT200500215A (es) 2006-03-27
DK1784409T3 (da) 2010-09-27
PE20060630A1 (es) 2006-08-03
HK1105198A1 (en) 2008-02-06
JP2008510712A (ja) 2008-04-10
EP1784409B1 (en) 2010-06-16
EP1784409A2 (en) 2007-05-16
CA2577879A1 (en) 2006-02-23
AU2005272584B2 (en) 2010-11-11
BRPI0514419A (pt) 2008-06-10
TWI372149B (en) 2012-09-11
PA8642801A1 (es) 2006-05-16
KR20070045263A (ko) 2007-05-02
US20070299112A1 (en) 2007-12-27
HRP20100475T1 (hr) 2010-10-31
JP4869232B2 (ja) 2012-02-08
JO2629B1 (en) 2012-06-24
PL1784409T3 (pl) 2010-10-29
US7393867B2 (en) 2008-07-01
SI1784409T1 (sl) 2010-10-29
ATE471326T1 (de) 2010-07-15
RU2403257C2 (ru) 2010-11-10
AU2005272584A1 (en) 2006-02-23
CN101001861A (zh) 2007-07-18
RU2007109812A (ru) 2008-09-27
SV2006002190A (es) 2006-05-24
IL181158A0 (en) 2007-07-04
US7652046B2 (en) 2010-01-26
CA2577879C (en) 2011-07-12
CN100562521C (zh) 2009-11-25
WO2006021000A3 (en) 2006-06-15
RS51413B (sr) 2011-02-28
MY139831A (en) 2009-10-30
DE602005021889D1 (en) 2010-07-29
WO2006021000A2 (en) 2006-02-23
PT1784409E (pt) 2010-09-06
US20080227822A1 (en) 2008-09-18
AR051008A1 (es) 2006-12-13
UY29077A1 (es) 2006-03-31

Similar Documents

Publication Publication Date Title
US7393867B2 (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I
ES2324871T3 (es) 1h-pirrolo(3,2-b, 3,2-c, y 2,3-c)piridina-2-carboxamidas sustituidas y analogos relacionados como inhibidores de caseina quinasa i epsilon.
US8008340B2 (en) 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase I
US7923466B2 (en) 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
HK1105198B (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
MXPA06005807A (en) Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon